Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.77
-0.10%
DAX
26,495.76
+0.40%
CAC 40
8,690.99
-0.27%
STOXX 50
6,559.62
+0.13%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Thursday 01 February 2024 3:37 pm  |  Updated:  Monday 05 February 2024 10:10 pm

Almost half of patients unaware of Government’s Pharmacy First scheme

By: Laura Forsyth

Add as a preferred source on Google
Patients can now receive treatment for seven common conditions without visiting a GP, thanks to a revamp of pharmacy services.
Patients can now receive treatment for seven common conditions without visiting a GP, thanks to a revamp of pharmacy services.

Patients can now receive treatment for seven common conditions without visiting a GP, thanks to a revamp of pharmacy services.

But despite the launch of the government and NHS England’s Pharmacy First scheme, nearly half of patients remain unaware of this initiative, according to a YouGov poll of 2,028 people across England, Scotland, and Wales.

The Pharmacy First Service (PFS) aims to position pharmacies as the frontline of healthcare, offering initial contact for patients and enhancing accessibility, especially with the NHS waiting list in England reaching 7.6 million. However, the survey indicates that only 23 per cent of patients presently consider pharmacies their first choice for minor conditions.

Upon learning about the PFS, 56 per cent of patients expressed willingness to turn to pharmacists instead of GPs for certain conditions, highlighting the need for increased awareness of pharmacy services. The survey, conducted by Charac, an NHS-integrated platform for community pharmacies, sheds light on the crucial role these establishments can play.

The seven conditions for which pharmacists can issue prescriptions include earache, uncomplicated urinary tract infections, sore throat, sinusitis, impetigo, shingles, and infected insect bites. Furthermore, patients can now obtain oral contraception directly from a pharmacy without the need to consult a practice nurse or GP.

Seven conditions pharmacists will be able to issue prescriptions for:

  • Sinusitis
  • Sore throat
  • Earache
  • Infected insect bites
  • Impetigo
  • Shingles
  • Uncomplicated urinary tract infections in women

Furthermore, a Pharmaceutical Services Negotiating Committee (PSNC) 2023 Pharmacy Pressures Survey
found that 81 per cent of pharmacy staff are ‘struggling to cope’ due to a significant rise in workload, and a
recent Education England (HEE) survey found that community vacancies doubled between
2017 and 2022.

Santosh Sahu, founder and CEO of Charac, said: “This sector has long voiced its concerns
about the introduction of Pharmacy First and we have seen first-hand how many community branches
are struggling to cope with an increase in demand.

“Ultimately, Pharmacy First will be vital in ensuring patients have easier access to healthcare, and for pharmacies to be able to provide a greater array of services to not only help their patients but also put them on a more sustainable financial position.

“Key to pharmacies being able to deliver on the new policy, we believe, is the digitisation of the sector,
giving them an online platform where they can more efficiently manage their administrative
processes and also offer new services, such as video consultations.

“Both funding and improved digital access can make a tangible difference in equipping them for
the future. Charac’s platform enhances pharmacies’ online presence, makes their processes more
efficient and helps them provide the broader range of services that will help take pressure off the NHS
and work to improve the nation’s health.”

Read more

NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Wellness

Related Topics

  • Health

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Hargreaves Lansdown orders staff back to office

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • Almirall H1 2026 Results

    Business Wire
  • Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Healthcare Professionals

    Business Wire
  • Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook